Caterpillar Inc vs TransMedics Group Inc — how do they compare? Caterpillar Inc trades at $864.9 (market cap $387.68B), while TransMedics Group Inc trades at $89.4 (market cap $3.10B). The key difference: Caterpillar Inc is far larger — about 125.1× TransMedics Group Inc's market cap, and Caterpillar Inc pays a 0.77% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| CAT | TMDX | |
|---|---|---|
Market Cap | $387.68B | $3.10B |
Sector | Industrials | Technology |
52-Week High | $1.06K | $150.42 |
52-Week Low | $407.79 | $61.99 |
Enterprise Value | $426.11B | $3.49B |
Dividend Yield | 0.77% | — |
Signals from Pluang's Aura AI — not financial advice
Caterpillar (CAT) trades at $837.58, down 0.55% on the day, with a bearish technical signal but strong fundamental performance. Recent quarters have consistently beaten EPS estimates, with Q2 2026 EPS of $8.17 surpassing the $6.22 expectation. Revenue growth is supported by AI data center demand, contributing to a robust $67.59B in 2025 revenue. The stock is near key support at $831, with resistance at $850.
Outlook remains positive due to strong earnings momentum and AI-driven infrastructure demand, though elevated valuation ratios (P/E of 36.32) pose a risk. Analyst consensus is bullish with a $1,010 price target, but investors should monitor macroeconomic pressures and competitive threats. The dividend history and cash flow stability add defensive appeal.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Caterpillar Inc. designs, manufactures, and markets construction, mining, and forestry machinery. The Company also manufactures engines and other related parts for its equipment, and offers financing and insurance. Caterpillar distributes its products through a worldwide organization of dealers.
Read more on CAT →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →